News
Larry Ellison, now Oracle’s CTO, has played a major role in helping the company win AI cloud deals and pivot beyond legacy ...
Oracle's stock surge is driven by AI hype, but revenue challenges and concentration risks suggest it’s overvalued. Click for ...
AI’s role in healthcare is no longer a question of if but how. In a Sept. 10 keynote at the Oracle Health and Life Sciences Summit in Orlando, Oracle Industries President Mike Sicilia and OpenAI Vice ...
Oracle is rated a strong buy with a $530 price target, driven by rapid growth in cloud and AI-related remaining performance ...
Defiance CEO Sylvia Jablonski on ORCX's amplified Oracle rally, the risks of leverage, and why single-stock ETFs suit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results